In the intricate landscape of pharmaceutical manufacturing, the role of intermediate compounds is paramount. These specialized chemicals serve as essential building blocks, paving the way for the creation of Active Pharmaceutical Ingredients (APIs) – the core therapeutic components of medications. Among these critical intermediates is 3-Fluoro-4-methoxyaniline, a compound renowned for its high purity and specific application in the pharmaceutical industry.

Pharmaceutical intermediates are fine chemical products that are synthesized at various stages in the production pathway of an API. Unlike APIs, which are the final active components intended for direct therapeutic use, intermediates do not typically possess pharmacological activity on their own. Their significance lies in their ability to facilitate complex chemical transformations, allowing for the precise construction of intricate molecular structures required for effective drugs. This multi-step synthesis approach ensures efficiency, rigorous quality control, and scalability in drug production. By breaking down the synthesis into manageable stages, manufacturers can detect and correct issues early, ensuring the purity and consistency of the final API.

3-Fluoro-4-methoxyaniline, identified by CAS No. 366-99-4, is a white crystalline powder with a purity of ≥99.0%. Its molecular formula is C7H8FNO, with a molecular weight of 141.14300. Key physical and chemical properties include a density of 1.176g/cm3, a melting point ranging from 81-83 °C, and a boiling point of 135 °C at 18 mm Hg. It has a flash point greater than 110 °C and an index of refraction of 1.531. These precise specifications underscore its suitability for demanding pharmaceutical applications. It is commonly used in the pharmaceutical industrial, serving as a crucial precursor in the synthesis of various drug compounds.

The global demand for high-quality pharmaceutical intermediates is steadily increasing, driven by the expansion of the pharmaceutical and biotechnology sectors, rising R&D activities, and the growing prevalence of chronic diseases. This surging demand emphasizes the critical need for reliable and quality-focused manufacturers. Ensuring the integrity of intermediates from raw material sourcing through the entire manufacturing process is crucial. Poor quality intermediates can lead to impurities in the final drug product, compromising efficacy and patient safety, and resulting in costly regulatory non-compliance. Therefore, stringent quality control and adherence to global regulatory standards, such as Good Manufacturing Practices (GMP), are non-negotiable for intermediate suppliers.

As a dedicated manufacturer and supplier, NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing high-quality 3-Fluoro-4-methoxyaniline to the global market. We understand that the integrity of this intermediate directly impacts the success of your pharmaceutical syntheses. Our product is meticulously packed in 25kg drums and requires specific storage conditions – keeping it away from heat, sparks, and flame, and storing it in a cool, dry, well-ventilated area in a tightly closed container, away from incompatible substances. For those looking to buy or purchase this essential compound, our focus on consistent quality and competitive price ensures that you receive a product that meets your exacting standards. We pride ourselves on being a trusted manufacturer and supplier, offering a reliable source for your pharmaceutical intermediate needs. For detailed product information or to inquire about procurement, please reach out to NINGBO INNO PHARMCHEM CO.,LTD., your partner in pharmaceutical chemical supply.